CapsoVision (CV) Receivables (2024 - 2025)
CapsoVision's (CV) quarterly Receivables came in at $2.5 million in Q4 2025, up 24.84% year-on-year from $2.0 million in Q4 2024, and up 33.58% quarter-over-quarter from $1.9 million in Q3 2025.
CapsoVision (CV) Receivables (2024 - 2025) Analysis & Trends
CapsoVision has disclosed Receivables across 2 years of filings, most recently posting $2.5 million for Q4 2025.
- Receivables for Q4 2025 came in at $2.5 million, up 24.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (up 24.84% YoY), and the FY2025 annual result was $2.5 million, up 24.84% from the prior year.
- Receivables came in at $2.5 million for Q4 2025 at CapsoVision, up from $1.9 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $2.5 million in Q4 2025 to a low of $1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.09 Bn |
| 10 | CapsoVision | 161.82 Mn | 151.71 Mn | 1.95 Mn | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.00 Mn |